Reviewed Mar 2026 | Sources: PubMed

CJC-1295 vs Sermorelin: Head-to-Head Comparison

Both are GHRH analogs but CJC-1295 was engineered for a dramatically longer half-life. Sermorelin has a 10-20 minute half-life requiring daily injections, while CJC-1295 with DAC lasts days. Sermorelin has the advantage of former FDA approval and a longer safety track record.

Side-by-Side Comparison

DimensionCJC-1295Sermorelin
Evidence LevelPhase II trials, published PK dataFormerly FDA-approved; decades of clinical use
FDA StatusNot approvedPreviously FDA-approved
MechanismModified GHRH(1-29) with Drug Affinity ComplexGHRH(1-29) analog, natural sequence
Half-Life~6-8 days (with DAC)~10-20 minutes
Dosing Frequency1-2x per week (DAC version)Daily injections required
Side EffectsInjection site reactions, water retentionFacial flushing, headache, injection pain
GH Release PatternSustained elevation (less physiological)Pulsatile, mimics natural rhythm
Evidence Level
CJC-1295
Phase II trials, published PK data
Sermorelin
Formerly FDA-approved; decades of clinical use
FDA Status
CJC-1295
Not approved
Sermorelin
Previously FDA-approved
Mechanism
CJC-1295
Modified GHRH(1-29) with Drug Affinity Complex
Sermorelin
GHRH(1-29) analog, natural sequence
Half-Life
CJC-1295
~6-8 days (with DAC)
Sermorelin
~10-20 minutes
Dosing Frequency
CJC-1295
1-2x per week (DAC version)
Sermorelin
Daily injections required
Side Effects
CJC-1295
Injection site reactions, water retention
Sermorelin
Facial flushing, headache, injection pain
GH Release Pattern
CJC-1295
Sustained elevation (less physiological)
Sermorelin
Pulsatile, mimics natural rhythm

Peptide Overviews

CJC-1295

BHuman Studies

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH). Available in two forms: with and without Drug Affinity Complex (DAC), which extends its half-life.

Growth Hormone SecretagoguesNot Approved
View full CJC-1295 profile →

Sermorelin

AFDA Approved

Sermorelin is the shortest fully functional fragment of GHRH (amino acids 1-29). It was the first GHRH analog approved by the FDA, marketed as Geref for diagnostic and therapeutic use.

Growth Hormone SecretagoguesFDA Approved
View full Sermorelin profile →

CJC-1295 vs Sermorelin: FAQ

Stay Informed on Peptide Research

Get weekly comparison updates, new study alerts, and regulatory changes.

No spam. Unsubscribe anytime.

Medical Disclaimer

This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.

Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.

No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.